The SRSP office has access to various databases with thousands of funding opportunities. Please call the office (301)319-7549 or send an email to peter.darpa@amedd.army.mil so that personalized funding searches can be done for your research.
SYNOPSIS: The sponsor provides support for recent postdoctoral (e.g., MD, PhD, DSc) graduates (including sub-specialty fellows) who have a demonstrated interest in vaccinology to attend an advanced vaccinology course in Les Pensières, Veyrierdu-Lac, France from May 10 - 21, 2010.
Program Announcement for Countermeasures Against Chemical Threats (CounterACT)
Exploratory/Developmental Projects in Translational Research (R21)(NOT-NS-09-018)
National Institute of Neurological Disorders and Stroke
The Bill & Melinda Gates Foundation is now accepting grant proposals for the Grand Challenges Explorations, a $100 million initiative to encourage bold and unconventional global health solutions.
Anyone can apply, regardless of your prior experience or institutional affiliation. Previous winners include graduate students, entrepreneurs at start-up companies, and creative thinkers from all fields of research.
Proposals are currently being accepted online until November 2, 2009 on the following topics:
* Create New Ways to Protect Against Infectious Disease
* Create Low-Cost Diagnostics for Priority Global Health Conditions
* Create New Ways to Induce and Measure Mucosal Immunity
* Create New Technologies for Contraception
Initial grants will be $100,000 each, and projects showing promise will have the opportunity to receive additional funding of up to $1 million. Full descriptions of topics and application instructions are available at: http://www.grandchallenges.org/explorations.
Dynamics of Host-Associated Microbial Communities (R01) (RFA-GM-11-001)
Sponsor: National Institute of General Medical Sciences
SYNOPSIS: Studies of model systems may provide useful tools to answer questions in this regard, such as: what factors distinguish microbes that comprise the core of the community from those that are transient; what are the key characteristics of niche environments that favor particular assemblages of microbes; by what means do the microbes in the community interact with each other and with the host, and how do the communities evolve – i.e., what is their natural history?
RFP--Amendment--Enabling Stress Resistance
Program Number: 04072
Sponsor: Defense Advanced Research Projects Agency
SYNOPSIS: DARPA is soliciting innovative research proposals in the area of Enabling Stress Resistance. This effort seeks a comprehensive mapping of the mechanisms involved in physical, affective, social and cognitive stress under both acute and chronic conditions in relevant animal models with the aim of developing and implementing interventions for stress prevention.
RFP-Development of Technologies to Facilitate the Use of, and Response to Biodefense Vaccines
Program Number:01941
Sponsor:National Institute of Allergy and Infectious Diseases/NIH/DHHS
The NIAID, Division of Microbiology and Infectious Diseases, has a requirement to advance the development of new medical countermeasures against the biological agents that are most likely to be used in a terror attack on civilian populations. Description The primary objective of this solicitation is to support the advanced development of a candidate product, which consists of a vaccine component and a delivery technology, for use in post-event settings following the intentional release of a biothreat agent or naturally occurring outbreaks of infectious diseases. In this type of setting, simplicity of operation and efficiency of delivery of the vaccine to and the effectiveness in large numbers of patients, are primary goals.
Partnerships for Development of Therapeutics and Diagnostics for Drug-Resistant Bacteria and Eukaryotic Parasites (R01) (RFA-AI-09-026)
National Institute of Allergy and Infectious Diseases
The US Special Operations Command is soliciting pre-proposals focused on applied biomedical research topics that may be of interest to Special Operations Forces (SOF)-relevant aspects of medical care, particularly related to: combat casualty management; medical aspects of mission planning, biomedical training, environmental protection, vibration/shock injury, diving procedures, equipment and injuries, exercise and mission related physiology, field diagnostic and care equipment; and medical information management systems. This notice constitutes a Broad Agency Announcement (BAA) as contemplated in FAR6.102 (d) (2). This solicitation is open to pre-proposals beginning 1 July 2009. Pre-proposals may be submitted after that date and until 30 Jun 2010. Pre-proposals will be reviewed on a quarterly basis.
Enterics Research Investigational Network Cooperative Research Centers (U19)
(RFA-AI-09-023)
Sponsor: National Institute of Allergy and Infectious Diseases
FUNDING: The sponsor will accept requests for funding that are below $125,000, as well as above it.
Duration: 1 YEAR(s)
Deadline Open:Yes
Established Date: 11/12/1980
Follow-Up Date:07/01/2010
Review Date:06/04/2009
DEADLINE NOTE
Grantseekers interested in obtaining funding from the sponsor are strongly encouraged to first submit a Letter of Inquiry.
SYNOPSIS: Support is generally provided to tax-exempt organizations for work in six broad subject matters: Basic Research; Science Education; Public Understanding of Science; Economic Performance and the Quality of Life; Select National Issues; and Civic Initiatives.
Identifying Non-coding RNA Targets for Cancer Early Detection and Prevention (R21) Program Number:02628 Sponsor: National Cancer Institute/NIH/DHHS Program URL:http://grants1.nih.gov/grants/guide/pa-files/PA-09-200.html Funding Limit:$275,000MAXIMUM Duration: 2 YEAR(s) Deadline(s):01/07/2010
01/07/2011
09/07/2010
05/07/2010
05/07/2011
09/07/2011
01/07/2012
05/07/2012
09/07/2012
10/16/2009
02/16/2010
06/16/2010
10/16/2010
02/16/2011
06/16/2011
10/16/2011
02/16/2012
06/16/2012
Established Date: 06/01/2009
Follow-Up Date:07/01/2010
Review Date:06/01/2009
SYNOPSIS: The sponsor invites applications from institutions/organizations on the discovery and characterization of non-coding (nc) RNAs in preneoplasias and early stage cancers to: 1) improve early cancer detection, intervention, and prevention; 2) predict risk of progression from preneoplasia to cancer, and 3) distinguish benign lesions from precancerous lesions. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.
Assay Development for High Throughput Molecular Screening (R21) Program Number: 95074 Sponsor:National Institute of Neurological Disorders and Stroke/NIH/DHHS Program URL:http://grants1.nih.gov/grants/guide/pa-files/PAR-08-024.html Deadline(s):11/06/2009 03/06/2010 11/20/2009 03/20/2010 Established Date: 11/12/2007 Follow-Up Date: 08/01/2009 Review Date: 05/07/2009 *See Restrictions for further information.
SYNOPSIS: The sponsors provide support for the development and adaptation of biological assays for use in automated High-Throughput Screening (HTS) projects. These HTS-ready assays can then be screened by the Molecular Libraries Production Centers Network (MLPCN) to identify biologically active compounds in a large library of small molecule chemical structures. This PAR is developed as part of an NIH Roadmap Molecular Initiative (http://nihroadmap.nih.gov), in which all NIH Institutes and Centers participate. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.
NIH - Planning Grants for International Malaria Clinical, Operational and Health Services Research Training Programs (D71) Grant
NIH/NIAID -- Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) - PA-07-093
Applications are solicited from organizations/institutions that propose to conduct vaccine-related research through well-established collaborations with Indian investigators on the following: dengue, influenza (including avian influenza), HIV/AIDS, and tuberculosis.
Application Receipt/Submission Date(s) - Standard dates apply: Feb 16, Jun 16, Oct 16.
DOD/MRMC BAA W81XWH-BAA07-1 Submission Deadline(s): Continuously open announcement. Preproposals may be submitted at any time for consideration. Preproposals that meet preliminary qualifications may be invited to submit full proposals. RESEARCH AREAS OF INTEREST: (A) Military Infectious Diseases Research Program; (B) Combat Casualty Care Research Program; (C) Military Operational Medicine Research Program; (D) Medical Biological Defense Research Program; (E) Medical Chemical Defense Research Program; (F) Telemedicine and Advanced Technology Program; (G) Special Programs Link to areas of interest: (http://www.usamraa.army.mil/pages/baa_paa/BAA07-1_Areas_Interest.pdf) Link to General Info and Proposal Preparation: http://www.usamraa.army.mil/pages/baa_paa/BAA07-1_Information.pdf
Deep Sequencing and Haplotype Profiling of Mental Disorders (R01) National Institute of Mental Health Application Receipt/Submission Date(s): Multiple dates, see announcement. http://grants.nih.gov/grants/guide/pa-files/PA-08-198.html
NIH/NIDCR Clinical Trial Planning Grant (R34)(PAR-08-195)
National Institute of Dental and Craniofacial Research
Application Receipt/Submission Date(s): Multiple dates, see announcement.
NIH/NIMH & Dept of Veterans’ Affairs Network(s) for Developing PTSD Risk Assessment Tools (R21) (RFA-MH-09-060) Letter of Intent: July 29, 2008 Full Proposal: August 29, 2008 Link to full announcement:http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-09-060.html
NIH - Immune Defense Mechanisms at the Mucosa (R21) Grant
NICHD/NINDS Multi-Drug Combinations to Promote Neurological recovery in Traumatic Brain Injury (R01) Optional Letter of Intent: October 28, 2008 Full Proposal: November 28, 2008 Link to announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-08-003.html
NIH Immunomodulatory, Inflammatory, and Vasoregulatory Properties of Transfused Red Blood Cell Units as a Function of Preparation and Storage (R01) Grant Letter of Intent:December 19, 2008 Full Proposals: January 21, 2009 Link to full announcement: http://www.grants.gov/search/search.do?&mode=VIEW&flag2006=true&oppId=17262
NIH - Addressing the Mental Health Needs of Returning Combat Veterans in the Community (R01) Application Due Date(s): October 28, 2008; May 1, 2009 Funds Available and Anticipated Number of Awards. ~$2.0 million in FY 2009 to fund 3 to 6 new grants; Budgets for direct costs of up to $499,999 per year may be requested. http://www.grants.gov/search/search.do?&mode=VIEW&flag2006=true&oppId=18141
NIH has designated at least $200 million in FYs 2009 - 2010 for a new initiative called the "NIH Challenge Grants in Health and Science Research" to fund 200 or more grants:http://grants.nih.gov/grants/funding/challenge_award/
Many of the topic areas are aligned with WRAIR's mission:
Funding: It is anticipated that contracts will be for a baseperiod (Phase I) and an option period (Phase II). The estimated potential totalvalues of all contracts combined is $20M.
Greater Mekong Subregion - Responses to Infectious Diseases (GMS-RID)
Proposals for funding are being sought from U.S. or non-U.S.
non-governmental organizations (NGOs) and/or a consortia to support regional and country-based infectious disease programs.This award will permit the recipient to carry out activities on a region-wide basis and/or in all of the following countries in the Greater Mekong Subregion (GMS): Cambodia, China, Laos, Thailand, Vietnam, and possibly Burma in the future.
Deadline(s):06/19/2009
Established Date: 05/11/2009
Follow-Up Date:06/01/2010
Review Date:05/11/2009
FUNDING:cooperative agreement of up to $4.4 million for a program not to exceed five years ($800,000 to $1 million annually)
Funding Limit: $75,000,000, Funding for this Cooperative Agreement is estimated to be $75 million over the five-year implementation period.
Duration:5 YEAR(s)
Deadline(s):07/15/2009
Established Date: 06/16/2009
Follow-Up Date:07/01/2010
Review Date:06/16/2009
SYNOPSIS: This is a cooperative agreement that will establish surveillance capacity for detecting, tracking and monitoring selected zoonotic microbial agents in wild animals in selected hotspots around the world. This agreement will focus attention on high risk microbes that pose a threat to human populations. It will monitor their movement and interaction with humans and also model their potential to become serious human health problems.
RESPOND - USAID Avian and Pandemic Influenza and Zoonotic Disease Program
Funding Limit: $185,000,000. Funding for this Cooperative Agreement is estimated to be $185 million over the five-year implementation period.
Duration:5 YEAR(s)
Deadline(s):07/15/2009
Established Date: 06/16/2009
Follow-Up Date:07/01/2010
Review Date:06/16/2009
SYNOPSIS: This is a cooperative agreement that will strengthen the human capacity of countries to respond to outbreaks of newly emergent diseases of animal origin in a timely and sustainable manner. The agreement will focus on the development of field epidemiology training in long term settings as well as short term in-service training programs. That training will emphasize the merging of animal and human health dynamics into a comprehensive capacity for disease detection and outbreak response.
International Collaborations in Infectious Disease Research (ICIDR) (U01)
Partnerships for Development of Vaccines for Selected Pathogens (R01)
(RFA-AI-09-016)
National Institute of Allergy and Infectious Diseases Application Receipt Date(s): July 27, 2009
NIAID invites research applications for projects that will advance development of vaccines against five pathogens that have a significant impact on public health: cytomegalovirus, respiratory syncytial virus, Staphylococcus aureus, Pseudomonas aeruginosa and Clostridium difficile.
The formation of collaborative partnerships between academic (or non-profit) researchers from different disciplines or with industry is strongly encouraged, but not required.
NIAID intends to commit $4.0 million in total costs in FY2010 to fund three to five applications.
Letters of Intent Receipt Date(s):June 26, 2009
NOTE: On-time submission requires that applications be successfully submitted to Grants.gov no later than 5:00 p.m. local time (of the applicant institution/organization) Application Due Date(s):July 27, 2009 Peer Review Date(s):November, 2009
***The deadline for the preproposal submission is 5:00 p.m. Eastern time, August 5, 2009. Preproposal submission is a required first step. An invitation letter is required to proceed to the second step of submitting a full proposal. The deadline for full proposal submission is 11:59 p.m. Eastern time, November 24, 2009.***
Funding Limit: $3,500,000MAXIMUM
Duration: 3 YEAR(s)
SYNOPSIS:
The sponsor seeks to fund research proposals that lead to evidence-based psychosocial, behavioral, pharmacological, and/or combined treatment of active duty Army Soldiers with “complicated” PTSD.The populations of interest for this funding opportunity include previously deployed, currently deployed, and post-deployed OIF/OEF active duty Army Soldiers with “complicated” PTSD.
Defense Medical Research and Development Program (DMRDP)--Applied Research and Advanced Technology Development Award
SYNOPSIS: The DMRDP Applied Research and Advanced Technology Development Award is being offered for the first time in FY10. These awards are intended to provide support for research that is designed to advance state-of–the-art solutions for world class medical care with an emphasis on post-traumatic stress disorder (PTSD), TBI, prosthetics, restoration of eye sight and advancing eye care, and other conditions directly relevant to the injuries our service members are currently receiving on the battlefield, as well as the capability needs of the JFHP CONOPS. DMRDP efforts will assess scientific and/or military field deployment feasibility of promising new products, pharmacologic agents (drugs and biologics), behavioral and rehabilitation interventions, diagnostic and therapeutic devices, clinical guidance, supporting medical information and training systems, and/or emerging approaches and technologies. These awards are expected to yield potential health products, approaches, or technologies positioned for human testing. Awards under this announcement will consist solely of assistance agreements.
RFA-HL-10-013--Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25) Program URL:http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-10-013.html Letters of Intent Receipt Date(s): July 29, 2009 Application Submission/Receipt Date(s): August 25, 2009 Peer Review Date(s): February/March 2010 Council Review Date(s): May 2010 Earliest Anticipated Start Date(s): July 1, 2010
Budget and Project Period: The estimated annual funds (total costs) available for the first year of support for the entire program are expected to be $900,000. The total project period for an application submitted in response to this funding opportunity may not exceed five years.
Purpose:This FOA issued by the National Heart, Lung, and Blood Institute, National Institutes of Health, solicits Research Education (R25) applications from institutions/organizations to promote diversity in undergraduate and health professional student populations by providing short-term research education support to stimulate career development in cardiovascular, pulmonary, hematologic, and sleep disorders research. The overall goal of the program is to provide research opportunities for individuals who are from diverse backgrounds underrepresented in biomedical and behavioral research. The National Science Foundation (NSF) has identified certain racial and ethnic minorities, and individuals with disabilities as underrepresented in biomedical and behavioral social science research (see data at http://www.nsf.gov/statistics/showpub.cfm?TopID=2&SubID=27 and the report Women, Minorities, and Persons with Disabilities in Science and Engineering, 2007, p.262). NIH also encourages the recruitment and participation of persons from disadvantaged backgrounds in all of its programs. The inclusion of individuals from these groups will significantly contribute to a diverse research workforce in the future.
RFP- Enabling Stress Resistance Program Number: 04072
Sponsor: Defense Advanced Research Projects Agency
Deadline:Initial Full Proposals are due by 4:00PM ET, August 24, 2009
SYNOPSIS:
DARPA is seeking innovative research proposals to create a comprehensive, quantitative description of the impact of stress on the brain.This effort seeks to leverage cutting-edge technologies and recent advances in molecular neurobiology, neuroimaging and molecular pathway modeling as applied to animal models of acute and chronic stress.The objective of the effort is a proactive approach to stress mitigation, starting with development of a comprehensive understanding of the complex effects of multiple stressors on the brain.The program has the ultimate goal of the development and implementation of cognitive, behavioral and/or pharmacological interventions that will prevent the deleterious effects of stress on the brain.DARPA envisions the creation of molecular mechanism ‘teams’ of researchers for a thorough investigation into the multiple pathways involved in the brain’s response to acute and chronic stress as well as physical, social, cognitive and affective stressors.Although motivation for the effort is derived from stresses associated with the operational environment, this effort will involve animal systems only. Proposals that involve human use, even if only a portion of the overall effort, will be deemed non-responsive.
International Centers of Excellence for Malaria Research (U19)
Letters of Intent Receipt Date: August 28, 2009 Application Receipt Date: September 29, 2009 Peer Review Date: January, 2010 Council Review Date: May, 2010 Earliest Anticipated Start Date:September, 2010
# Funds Available and Anticipated Number of Awards. The NIAID intends to commit $13.8M in total costs in fiscal year 2010 to fund 7-12 new grants in response to this FOA.
